New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2014
07:19 EDTMYGNMyriad Genetics price target raised to $44 from $42 at Cantor
Cantor increased its price target on Myriad Genetics after CMS raised prices for the company's BRCA 1&2 tests by about 52%, according to the firm. Cantor raised its estimates for Myriad Genetics and keeps a Buy rating on the stock.
News For MYGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 24, 2015
16:28 EDTMYGNMyriad Genetics board approves $200M increase in share buyback program
Subscribe for More Information
February 17, 2015
10:53 EDTMYGNScopia Capital reports 5.87% passive stake in Myriad Genetics

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use